The Hepatitis B vaccine, once a significant public health success, is facing potential challenges. Since 1991, when all newborns received the vaccination, rates of the disease have steadily decreased. Recent statements from President Trump suggest a potential reconsideration of the vaccination schedule, with a focus on delaying vaccination until age 12. While the vaccine remains effective, this shift in policy could impact the continued reduction of the disease’s prevalence. Official data indicates a continued decline in infection rates across the United States.
Credits: NYT > Top Stories